Headline: Boston Scientific Corp Profit Surges in Q4 - BSX

[Para 1: The Lead] Boston Scientific Corp (BSX) reported a significant profit increase of 15% in the fourth quarter, exceeding analysts' expectations. The company's revenue climbed 8% to $3.2 billion, bolstering its bottom line. This financial performance reflects robust demand for its medical devices and services. [Para 2-3: Supporting details & Context] The earnings per share (EPS) rose to $2.15, up from $1.88 in the same period last year. Boston Scientific attributed the growth to strong sales in its vascular and neuromodulation segments. The company also announced a 10% increase in its dividend, signaling confidence in its financial health. Analysts are optimistic about the company's future prospects, with shares of BSX rising 5% in after-hours trading.